Hormone Panel & Bioidentical Hormone Therapy Consult

Next Health offers hormone evaluation as part of their Baseline Blood Test ($349), covering cortisol, testosterone, estrogen, DHEA, and related markers. Advanced hormone optimisation including bioidentical hormone replacement therapy (BHRT) for men and women is accessible through the Medicine 4.0 Membership, with quarterly provider follow-up consults. Ideal for individuals experiencing low energy, poor sleep, body composition changes, or other signs of hormonal imbalance.

Hormone evaluation at Next Health San Francisco begins with the Baseline Blood Test ($349), which includes cortisol, total testosterone, free testosterone (calculated), estradiol, DHEA-S, and SHBG as part of its 50+ biomarker panel. These markers allow an initial assessment of adrenal, gonadal, and anabolic hormone status — a clinically meaningful starting point given the well-documented decline in sex hormone levels that begins in the third and fourth decade of life and accelerates with age. For individuals whose hormone panels indicate suboptimal levels — or who are experiencing symptoms consistent with hormonal imbalance such as fatigue, poor sleep, reduced libido, mood changes, or changes in body composition — Next Health's Medicine 4.0 Membership provides access to a more advanced hormone programme, which includes bioidentical hormone replacement therapy (BHRT). BHRT uses hormones that are structurally identical to those naturally produced by the body — typically compounded bioidentical testosterone (for men and women), estradiol, progesterone, and DHEA — as opposed to synthetic hormone analogues. For men, testosterone optimisation protocols may include topical gels, injections, or pellet implants; for women, oestrogen and progesterone replacement may be offered in forms appropriate to menopausal or perimenopausal status. The Medicine 4.0 Membership model includes quarterly follow-up consultations with a Next Health medical provider, allowing ongoing dose titration based on repeat bloodwork and symptom response. At the entry point, the $349 Baseline Test with its hormone markers is the recommended first step before any hormone optimisation discussion.